MRF (MRF) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
1 Sep, 2025Executive summary
Board approved unaudited standalone and consolidated results for the quarter and half year ended 30th September 2024, with an interim dividend of Rs.3 per share declared, record date set for 19th November 2024.
Statutory auditors issued limited review reports with no material misstatements identified in both standalone and consolidated results.
Financial highlights
Standalone revenue from operations for Q2 FY25 was Rs.6,760.37 crore, up from Rs.6,087.56 crore in Q2 FY24; half-year revenue at Rs.13,838.21 crore versus Rs.12,410.84 crore year-over-year.
Standalone net profit for Q2 FY25 was Rs.455.43 crore, compared to Rs.571.93 crore in Q2 FY24; half-year net profit at Rs.1,017.98 crore versus Rs.1,153.38 crore year-over-year.
Consolidated revenue from operations for Q2 FY25 was Rs.6,881.09 crore, up from Rs.6,217.10 crore in Q2 FY24; half-year revenue at Rs.14,077.54 crore versus Rs.12,657.39 crore year-over-year.
Consolidated net profit for Q2 FY25 was Rs.470.70 crore, compared to Rs.586.66 crore in Q2 FY24; half-year net profit at Rs.1,041.72 crore versus Rs.1,175.41 crore year-over-year.
Outlook and guidance
CARE reaffirmed ratings at "CARE AAA" for long-term and "CARE A1+" for short-term banking facilities and NCDs.
Latest events from MRF
- Strong revenue and profit growth, improved margins, and a Rs.3 interim dividend declared.MRF
Q3 25/266 Feb 2026 - Strong revenue and profit growth with interim dividend declared and robust financial ratios.MRF
Q2 25/2614 Nov 2025 - Revenue and profit rose year-over-year, but margins declined; CCI penalty remains under appeal.MRF
Q1 24/251 Sep 2025 - Revenue rose but net profit dipped; record dividend of Rs 235/share declared for FY25.MRF
Q4 24/251 Sep 2025 - Revenue up but profit and margins down; Rs.3 interim dividend declared; legal risk persists.MRF
Q3 24/251 Sep 2025 - Revenue growth continues, but net profit margins soften; financials remain robust.MRF
Q1 25/261 Sep 2025